Trial Profile
Effects of EUS-guided fine-needle injection (EUS-FNI) of STNM01, on tumor growth, histology, and overall survival in patients with unresectable pancreatic cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Nov 2017
Price :
$35
*
At a glance
- Drugs STNM 01 (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions
- 20 Nov 2017 New trial record
- 06 Nov 2017 Results published in the Gastrointestinal Endoscopy